These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
476 related articles for article (PubMed ID: 33914025)
1. Modeling Strategies to Optimize Cancer Screening in USPSTF Guideline-Noncompliant Women. Taksler GB; Peterse EFP; Willems I; Ten Haaf K; Jansen EEL; de Kok IMCM; van Ravesteyn NT; de Koning HJ; Lansdorp-Vogelaar I JAMA Oncol; 2021 Jun; 7(6):885-894. PubMed ID: 33914025 [TBL] [Abstract][Full Text] [Related]
2. The aggregate value of cancer screenings in the United States: full potential value and value considering adherence. Philipson TJ; Durie T; Cong Z; Fendrick AM BMC Health Serv Res; 2023 Aug; 23(1):829. PubMed ID: 37550686 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force. Meza R; Jeon J; Toumazis I; Ten Haaf K; Cao P; Bastani M; Han SS; Blom EF; Jonas DE; Feuer EJ; Plevritis SK; de Koning HJ; Kong CY JAMA; 2021 Mar; 325(10):988-997. PubMed ID: 33687469 [TBL] [Abstract][Full Text] [Related]
4. Estimated US Cancer Deaths Prevented With Increased Use of Lung, Colorectal, Breast, and Cervical Cancer Screening. Knudsen AB; Trentham-Dietz A; Kim JJ; Mandelblatt JS; Meza R; Zauber AG; Castle PE; Feuer EJ JAMA Netw Open; 2023 Nov; 6(11):e2344698. PubMed ID: 37991759 [TBL] [Abstract][Full Text] [Related]
5. Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling Analysis. Lowry KP; Geuzinge HA; Stout NK; Alagoz O; Hampton J; Kerlikowske K; de Koning HJ; Miglioretti DL; van Ravesteyn NT; Schechter C; Sprague BL; Tosteson ANA; Trentham-Dietz A; Weaver D; Yaffe MJ; Yeh JM; Couch FJ; Hu C; Kraft P; Polley EC; Mandelblatt JS; Kurian AW; Robson ME; JAMA Oncol; 2022 Apr; 8(4):587-596. PubMed ID: 35175286 [TBL] [Abstract][Full Text] [Related]
6. Changes in Health Care Access and Preventive Health Screenings by Race and Ethnicity. Alba C; Zheng Z; Wadhera RK JAMA Health Forum; 2024 Feb; 5(2):e235058. PubMed ID: 38306093 [TBL] [Abstract][Full Text] [Related]
7. Collaborative Modeling to Compare Different Breast Cancer Screening Strategies: A Decision Analysis for the US Preventive Services Task Force. Trentham-Dietz A; Chapman CH; Jayasekera J; Lowry KP; Heckman-Stoddard BM; Hampton JM; Caswell-Jin JL; Gangnon RE; Lu Y; Huang H; Stein S; Sun L; Gil Quessep EJ; Yang Y; Lu Y; Song J; Muñoz DF; Li Y; Kurian AW; Kerlikowske K; O'Meara ES; Sprague BL; Tosteson ANA; Feuer EJ; Berry D; Plevritis SK; Huang X; de Koning HJ; van Ravesteyn NT; Lee SJ; Alagoz O; Schechter CB; Stout NK; Miglioretti DL; Mandelblatt JS JAMA; 2024 Jun; 331(22):1947-1960. PubMed ID: 38687505 [TBL] [Abstract][Full Text] [Related]
8. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic. Chen RC; Haynes K; Du S; Barron J; Katz AJ JAMA Oncol; 2021 Jun; 7(6):878-884. PubMed ID: 33914015 [TBL] [Abstract][Full Text] [Related]
9. County-Level Social Vulnerability and Breast, Cervical, and Colorectal Cancer Screening Rates in the US, 2018. Bauer C; Zhang K; Xiao Q; Lu J; Hong YR; Suk R JAMA Netw Open; 2022 Sep; 5(9):e2233429. PubMed ID: 36166230 [TBL] [Abstract][Full Text] [Related]
10. USPSTF colorectal cancer screening guidelines: an extended look at multi-year interval testing. Berger BM; Parton MA; Levin B Am J Manag Care; 2016 Feb; 22(2):e77-81. PubMed ID: 26881323 [TBL] [Abstract][Full Text] [Related]
11. Women's Health Maintenance Efforts at a Student-Run Free Clinic in South Florida Exceeded National Trends During the COVID-19 Pandemic. Johnson G; Miquel-Chambers C; Blas Y; Lowery S; Guerra L; Gonzalez E J Community Health; 2023 Jun; 48(3):501-507. PubMed ID: 36719533 [TBL] [Abstract][Full Text] [Related]
12. [Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates]. Mantellini P; Battisti F; Armaroli P; Giubilato P; Ventura L; Zorzi M; Battagello J; Sassoli de Bianchi P; Senore C; Zappa M Epidemiol Prev; 2020; 44(5-6 Suppl 2):344-352. PubMed ID: 33412828 [TBL] [Abstract][Full Text] [Related]
13. Benefits and Harms of Mammography Screening for Women With Down Syndrome: a Collaborative Modeling Study. Alagoz O; Hajjar A; Chootipongchaivat S; van Ravesteyn NT; Yeh JM; Ergun MA; de Koning HJ; Chicoine B; Martin B J Gen Intern Med; 2019 Nov; 34(11):2374-2381. PubMed ID: 31385214 [TBL] [Abstract][Full Text] [Related]
14. Comparative Effectiveness of 2 Interventions to Increase Breast, Cervical, and Colorectal Cancer Screening Among Women in the Rural US: A Randomized Clinical Trial. Champion VL; Paskett ED; Stump TE; Biederman EB; Vachon E; Katz ML; Rawl SM; Baltic RD; Kettler CD; Seiber EE; Xu WY; Monahan PO JAMA Netw Open; 2023 Apr; 6(4):e2311004. PubMed ID: 37115541 [TBL] [Abstract][Full Text] [Related]
15. Breast, Cervical, and Colorectal Cancer Screening Adherence: Effect of Low Body Mass Index in Women. Charkhchi P; Schabath MB; Carlos RC J Womens Health (Larchmt); 2020 Jul; 29(7):996-1006. PubMed ID: 31928405 [No Abstract] [Full Text] [Related]
16. Adherence to US Preventive Services Task Force recommendations for breast and cervical cancer screening for women who have a spinal cord injury. Xu X; Mann JR; Hardin JW; Gustafson E; McDermott SW; Deroche CB J Spinal Cord Med; 2017 Jan; 40(1):76-84. PubMed ID: 27077580 [TBL] [Abstract][Full Text] [Related]
17. The Effect of Disability and Social Determinants of Health on Breast and Cervical Cancer Screenings During the COVID-19 Pandemic. Rolle LD; Chery MJ; Larson M; Lopez-Pentecost M; Calfa CJ; Schlumbrecht MP; Crane TE Prev Chronic Dis; 2024 Jan; 21():E05. PubMed ID: 38271492 [TBL] [Abstract][Full Text] [Related]